Accelerate Diagnostics (AXDX) Misses Q2 EPS by 222c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts AXDX Hot Sheet
Join SI Premium – FREE
Accelerate Diagnostics (NASDAQ: AXDX) reported Q2 EPS of ($2.36), $2.22 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.92 million versus the consensus estimate of $3.6 million.
For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Herc Holdings (HRI) Tops Q3 EPS by 95c ; Offers Guidance
- Applied Industrial Technologies (AIT) Tops Q1 EPS by 9c ; Offers Guidance
- CMS Energy (CMS) Tops Q3 EPS by 21c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
